Healing with Praying Medic
Posted inHumanity

Healing with Praying Medic

Dave Hayes goes by the pen name Praying Medic, and from late 2021 he has ramped up his teaching and healing ministry, this page provides easy access to some key videos. Since Dave opened a Telegram channel in 2022, he…
24 May 2022Posted inHumanity

First COVID-19 vaccine administered in US

The first COVID-19 vaccine administered in America was to Sandra Lindsey, an ICU nurse, in New York City on December 14, 2020. After months of vaccine development, two companies, Pfizer-BioNTech and Moderna applied to the FDA for Emergency Use Authorization (EUA).  To receive approval, the companies’ data had to be reviewed by the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP), which determined that health care workers and long-term care residents should be the first groups to receive the vaccine. [1, 2, 3, 4] In a press release on December 10, 2020 the FDA assured the public that they would proceed "without sacrificing our rigorous scientific standards for safety and effectiveness."  "The FDA recognizes that transparency and dialogue are critical to building public confidence in COVID-19 vaccines." "The FDA is considered the "gold standard" regulator of medical products. The process that the FDA uses to review is respected worldwide..." On December 10, 2020 The FDA's Center for Biologics Evaluation and Research’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), "made up of independent scientific and public health experts from around the country", met in open session to discuss the request for EUA of..> READ MORE

FDA warns HCQ could cause severe heart problems in COVID-19 patients

In a press release on April 24, 2020, the FDA "warned providers not to use the anti-malaria drugs chloroquine and hydroxychloroquine to treat COVID-19 patients outside of a clinical trial or hospital setting because the drugs could cause patients to experience "serious heart rhythm problems." [1] On March 28, 2020, the FDA has granted Emergency Use Authorisation (EUA) for the use of "hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile (SNS) to be distributed and used in limited circumstances, such as for certain hospitalized patients with COVID-19."  Thus with this wording on the EUA for an already approved drug, doctors felt they could not prescribe it for out-patients. On Sunday April 5, 2020, "Vice President Pence announced that a 3,000-person study on the effectiveness of hydroxychloroquine as a COVID-19 treatment would take place at Henry Ford Hospital."  Which turned out to have a mortality benefit. By June 15, 2020 the FDA REVOKED the EUA for HCQ on the back of the fraudulent Lancet study (published May 22, 2020) alleging heart problems, but RETRACTED on June 4, 2020. All official studies were done in hospitalised patients, including the WHO Solidatiry trials with excessive dosages, where as success on the ground..> READ MORE

President Trump freezes US funding to WHO

On April 15, 2020, President Trump stated the US will freeze World Health Organisation (WHO) funding for 60-90 days, pending a formal investigation into the global health agency's response to the global COVID-19 pandemic.  Trump repeatedly signaled the move after accusing the WHO of having a bias in favor of China. On July 7, 2020 President Trump took the first formal step toward withdrawing the U.S. from the WHO by submitting a "notice of withdrawal" to the United Nations secretary-general, making the parting effective July 6, 2021.  Withdrawing from the organization requires a one-year notice before becoming final. On September 2, 2020, Trump cancels $62M of US funding for World Health Organization, "which was slated to receive $120 million in the 2020 fiscal year from the United States."  In 2019 the US contributed $450 million, accounting  for 15% of it's total budget. In January 2021, Biden stopped this move and rejoined the US to the WHO.

First confirmed case of Monkeypox in non-endemic UK

On 7 May 2022, WHO was informed of a confirmed case of monkeypox in an individual who returned from Nigeria where the disease is endemic.   The case developed a rash on 29 April 2022 and arrived in the United Kingdom on 4 May, departing Nigeria on 3 May. By May 22 the WHO reported on Twitter that there are 11 non-enemic countries with "about 80 confirmed cases, and 50 pending investigations" with more likely to be reported, and travel links have not been established. Endemic monkeypox disease is normally geographically limited to West and Central Africa. [1, 2] It is reported that monkeypox has been found in an ‘atypical’ spread in several countries including the United States, Spain, Canada and Australia, and "could accelerate in the coming months", prompting an emergency meeting by the WHO. This world’s first-ever global outbreak of Monkeypox has occurred, just one year after an international biosecurity conference in Munich held a simulation of a “global pandemic involving an unusual strain of Monkeypox” beginning in mid-May 2022! [3] The UK is stockpiling vaccines as they fear cases are being missed, as the majority of cases are not linked, suggesting it is spreading more widely. Bill..> READ MORE
Dr Russell Blaylock
Posted inCredentialed Experts

Dr Russell Blaylock

Dr Russell Blaylock is a board-certified neurosurgeon, health practitioner, author, and lecturer. He attended the Louisiana State University School of Medicine and completed his internship and neurological residency at the Medical University of South Carolina. For 26 years he practiced…
21 May 2022Posted inCredentialed Experts

FDA sets a low efficacy requirement of 50% for COVID-19 vaccines, WHO sets 70%

In a press release on June 30, 2020 the US FDA issued guidance to manufacturers "help facilitate the timely development of safe and effective vaccines to prevent COVID-19" in order to win regulatory approval. [7] "The guidance also discusses the importance of ensuring that the sizes of clinical trials are large enough to demonstrate the safety and effectiveness of a vaccine. It conveys that the FDA would expect that a COVID-19 vaccine would prevent disease or decrease its severity in at least 50% of people who are vaccinated." Also the vaccine companies would be required to monitor the vaccine’s performance after approval for any emerging safety problems. [1, 2, 3] “If you had a 60 or 70 percent effective vaccine and everybody took it, you might actually be reaching toward herd immunity and potentially then dampen down this pandemic,” Dr George Poland of the Mayo Clinic said on Nov 3, 2020. As a comparison the flu vaccine effectiveness which "can vary widely from year to year has been anywhere from 20% to 60% effective over the last decade. According to GlobalData on April 9, 2020 the WHO sets two vaccine success benchmarks for vaccines.  "Preferably, the vaccine should have at..> READ MORE